Challenging times demand innovation. That’s especially true today, as we find ourselves in the middle of a mental health crisis that has been exacerbated by the COVID-19 pandemic.
For patients living with major depressive disorder, this puts strain on a population that has seen little treatment innovation in decades, leaving millions inadequately served by current options.
But the future looks promising. Renewed interest in the development of psychedelic therapies for mental health is demonstrating potential for new treatments – and introducing questions.
We’ll address them and explore the possibilities during “Rediscovering Mental Health Innovation: Emerging Psychedelic Therapies” on Thursday, July 29, from 12-1 p.m. ET.
Join us as we review the latest research, examine the science and discuss considerations with experts, while examining the challenges that come with reimagining care delivery.
Don’t miss this forward-looking discussion on the potential of psychedelic therapies and the possible implications throughout our field – register today! Questions? Contact us!
Comments (0)